Fused thiazole derivatives as kinase inhibitors

Details for Australian Patent Application No. 2008269577 (hide)

Owner UCB Pharma S.A.

Inventors Franklin, Richard Jeremy; Aujla, Pavandeep Singh; Alexander, Rikki Peter; Crepy, Karen Viviane Lucile; Foley, Anne Marie

Agent Watermark

Pub. Number AU-A-2008269577

PCT Pub. Number WO2009/001089

Priority PCT/ GB2007/002390 26.06.07 GB

Filing date 24 June 2008

Wipo publication date 31 December 2008

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/437 (2006.01)

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

C07D 513/12 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

C07D 519/00 (2006.01) Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

28 January 2010 PCT application entered the National Phase

  PCT publication WO2009/001089 Priority application(s): WO2009/001089

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008269580-A bioerodible patch

2008269575-New medical products